INX 200
Alternative Names: INX-200Latest Information Update: 25 Aug 2023
At a glance
- Originator ImmuNext
- Class Drug conjugates; Glucocorticoids; Monoclonal antibodies; Pregnadienediols
- Mechanism of Action Glucocorticoid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Autoimmune disorders
Most Recent Events
- 31 May 2023 Preclinical trials in Autoimmune disorders in USA (unspecified route)
- 31 May 2023 Pharmacokinetics, pharmacodynamics and adverse events data from a preclinical trial in Autoimmune disorder presented at the 24th Annual Congress of the European League Against Rheumatism (EULAR-2023)
- 07 Jan 2022 Immunext has worldwide patent pending for antibody drug conjugate